U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT03394755) titled 'Thrombosomes(R) in Bleeding Thrombocytopenic Patients' on Jan. 3, 2018.
Brief Summary: This study evaluates in a dose-escalation manner, the safety, and preliminary impact on bleeding, and the preliminary effect on coagulation measures of increasing doses of allogeneic Thrombosomes in thrombocytopenic patients.
Study Type: Interventional
Condition: * Thrombocytopenia
* Hematologic Diseases
* Bone Marrow Aplasia
Intervention: Biological: Thrombosomes
Freeze-dried platelets
Recruitment Status: Recruiting
Sponsor: Cellphire, Inc.
Information provided by (Responsible Party): Cellphire, Inc.
Published by HT Digital Content Serv...